Celularity (CELU) - 2023 Q3 - Quarterly Report

As of September 30, 2023, the Company had 70,706,345 outstanding warrants to purchase Class A common stock. A summary of the warrants is as follows: Awards with Service Conditions In September 2021, the Company awarded options to acquire a total of 2,469,282 shares with an exercise price of $6.32 to the Company's former President in connection with the commencement of his employment. The grant was comprised of four equal tranches, and would vest in up to five equal installments in respect of achieving certa ...